WHO recommends Pfizer's corona pill

The World Health Organization has found that the risk of hospital admission was 85 percent lower for patients treated with the drug.
Photo: Frank Hoermann/AP/Ritzau Scanpix
Photo: Frank Hoermann/AP/Ritzau Scanpix
by ritzau, translated by catherine brett

A pill-based treatment for Covid-19 developed by Pfizer has received a strong recommendation from the World Health Organization (WHO).

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading